News 05 Mar 2024 Immunocore turns to Oncobit platform The British biotechnology company Immunocore will in future make use of the platform developed by Oncobit, a medtech firm and spin-off from the U...
Aktuell 05 Mar 2024 Immunocore setzt auf Plattform von Oncobit Die britische Biotech-Firma Immunocore nutzt in Zukunft die Plattform des Medtech-Unternehmens Oncobit, einer Ausgliederung der Universität Züric...
Registrazioni video 18 Ene 2024 Cogliere le opportunità dell'industria ferroviaria coreana Guardate la registrazione del nostro webinar esclusivo sull'industria ferroviaria coreana, dove la storia incontra la tecnologia d'avanguardia. S...
News 21 Mayo 2024 InSphero partners with Genome Biologics The biotech company InSphero has signed an agreement with Genome Biologics to commercialize the 3D Cardiac Organoid Platform. The platform is at ...
News 17 Abr 2024 Symbio invests CHF 12 million in new research facility in Corminboeuf Symbio commits CHF 12 million to establish a high-tech hydrogen research center in Corminboeuf, aiming for a 2026 launch.
Voyages pour PME Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mayo 2024–16 Mayo 2024 Armenia
Fact-Finding Mission Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mayo 2024–16 Mayo 2024 Armenia
Viaggi per imprenditori Prospettive dell’idrogeno: alla scoperta del settore delle energie rinnovabili in Marocco 07 Oct 2024–11 Oct 2024 Marruecos
Factsheet 01 Ago 2023 Opportunità sul mercato ferroviario coreano Informazioni sull'industria ferroviaria coreana, sui suoi attori principali, sui grandi progetti in atto, così come sulle sfide e sulle opportuni...
News 10 Mayo 2024 BioVersys extends Series C financing round to 44.9 million Swiss francs BioVersys is bolstering its partnership with GSK in order to accelerate the development of alpibectir for the treatment of tuberculosis. GSK is s...
Aktuell 22 Ene 2024 DISCO Pharmaceuticals startet mit 20 Millionen Euro Kapital DISCO Pharmaceuticals ist mit einem Startkapital von 20 Millionen Euro neu auf dem Markt. Sein Team hat als erstes eine Methode entwickelt, die e...
News 26 Mar 2024 Top Stories from Western Switzerland (March 2024) From innovative approaches in cardiac care and sustainable plastics to enhancing spinal cord injury therapies and advancing virtual power plants,...
News 07 Mayo 2024 UZH researching innovative cancer therapy Researchers from the University of Zurich (UZH) are in the process of developing new cancer therapeutics. Known as radiotheranostics, these drugs...
Unternehmerreisen Swiss Days Armenia and Swiss Business Delegation to EBRD Business Forum 13 Mayo 2024–16 Mayo 2024 Armenia